Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Potepan

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 3, 2009
Further improvement in outcomes of nasopharyngeal carcinoma with optimized radiotherapy and induction plus concomitant chemotherapy: an update of the Milan experienceMauro Palazzi, Ester Orlandi, Paolo Bossi, et al.
International Journal of Radiation Oncology, Biology, Physics|September 21, 2007
Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring systemMauro Palazzi, Stefano Tomatis, Ester Orlandi, et al.
Head & Neck|December 19, 2014
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancersLaura D Locati, Federica Perrone, Barbara Cortelazzi, et al.
Oral Oncology|February 2, 2013
Tp53 status as guide for the management of ethmoid sinus intestinal-type adenocarcinomaPaolo Bossi, Federica Perrone, Rosalba Miceli, et al.
Neuro-Oncology|February 1, 2014
Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trialGraziella Cefalo, Maura Massimino, Antonio Ruggiero, et al.
Future Oncology (London, England)|December 21, 2012
Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinomaEster Orlandi, Stefano Tomatis, Paolo Potepan, et al.
Journal of Neuro-Oncology|February 13, 2010
A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade gliomaMaura Massimino, Filippo Spreafico, Daria Riva, et al.
Journal of Neurosurgery. Pediatrics|September 3, 2011
Second-look surgery for ependymoma: the Italian experienceMaura Massimino, Carlo Lazzaro Solero, Maria Luisa Garrè, et al.
International Journal of Radiation Oncology, Biology, Physics|November 21, 2008
No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastomaMaura Massimino, Lorenza Gandola, Filippo Spreafico, et al.
Journal of Neuro-Oncology|April 4, 2014
Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhoodMaura Massimino, Veronica Biassoni, Rosalba Miceli, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|March 3, 2009
Further improvement in outcomes of nasopharyngeal carcinoma with optimized radiotherapy and induction plus concomitant chemotherapy: an update of the Milan experienceMauro Palazzi, Ester Orlandi, Paolo Bossi, et al.
International Journal of Radiation Oncology, Biology, Physics|September 21, 2007
Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring systemMauro Palazzi, Stefano Tomatis, Ester Orlandi, et al.
Head & Neck|December 19, 2014
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancersLaura D Locati, Federica Perrone, Barbara Cortelazzi, et al.
Oral Oncology|February 2, 2013
Tp53 status as guide for the management of ethmoid sinus intestinal-type adenocarcinomaPaolo Bossi, Federica Perrone, Rosalba Miceli, et al.
Neuro-Oncology|February 1, 2014
Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trialGraziella Cefalo, Maura Massimino, Antonio Ruggiero, et al.
Future Oncology (London, England)|December 21, 2012
Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinomaEster Orlandi, Stefano Tomatis, Paolo Potepan, et al.
Journal of Neuro-Oncology|February 13, 2010
A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade gliomaMaura Massimino, Filippo Spreafico, Daria Riva, et al.
Journal of Neurosurgery. Pediatrics|September 3, 2011
Second-look surgery for ependymoma: the Italian experienceMaura Massimino, Carlo Lazzaro Solero, Maria Luisa Garrè, et al.
International Journal of Radiation Oncology, Biology, Physics|November 21, 2008
No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastomaMaura Massimino, Lorenza Gandola, Filippo Spreafico, et al.
Journal of Neuro-Oncology|April 4, 2014
Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhoodMaura Massimino, Veronica Biassoni, Rosalba Miceli, et al.
Pageof 3